Company Filing History:
1 out of 143 
1 out of 1 Years Active: 2006
Title: Michael Felder: Innovator in Topoisomerase Linker-Mediated Amplification Methods
Introduction
Michael Felder, an inventive mind based in Columbia, SC, has made significant contributions to the field of genetic research through his patented work. With a focus on topoisomerase linker-mediated amplification methods, his invention enhances the capabilities of DNA manipulation and analysis.
Latest Patents
Felder holds one prominent patent titled "Topoisomerase linker-mediated amplification methods." This innovation introduces a Vaccinia topoisomerase-adapted linker that features an oligonucleotide primer binding site of known sequence. The primary utility of this invention lies in its ability to specifically join the linker to the end of a polynucleotide of unknown sequence, thereby facilitating subsequent PCR amplification of the polynucleotide or DNA. The patent also includes kits containing the linker and one or more linker-specific oligonucleotides, designed for efficient use in PCR processes. Additionally, the patent outlines methods to utilize these linkers in amplification procedures for isolating and optionally sequencing the amplification products.
Career Highlights
Throughout his career, Michael Felder has collaborated with prestigious organizations such as Invitrogen Corporation and the South Carolina Research Institute. His work in these institutions has undoubtedly contributed to advancements in biotechnological research.
Collaborations
Felder's innovative journey has included collaborations with notable colleagues, including John A Heyman and Gabor Szalai. Working alongside these professionals has enriched his research and broadened the impact of his inventions.
Conclusion
Michael Felder stands out as an inventor whose work has significantly influenced the realm of genetic research, particularly through his patented techniques in link-mediated amplification. His contributions continue to pave the way for advancements in biotechnology, showcasing the importance of innovation in this critical field.